Prostate mpMRI in the UK: the state of the nation
The article discusses how advancements in multiparametric MRI (mpMRI) are enhancing prostate cancer diagnosis by reducing unnecessary biopsies and targeting significant cancers, despite ongoing challenges like geographical variation and limited resources.
Prostate Cancer Essentials: Part 1 – Introduction to Prostate Cancer
A course providing an introduction to the prostate and prostate cancer covering all of the essential information for healthcare professionals who have taken on a role supporting people affected by cancer.
Is the digital rectal exam any good as a prostate cancer screening test?
The article critiques the digital rectal examination (DRE) for prostate cancer screening, highlighting its limitations compared to multi-parametric MRI (mpMRI) and discussing emerging methods from the TRANSFORM trial to improve detection and reduce unnecessary procedures.
The impact of pre-biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
The article finds that adding pre-biopsy MRI to standard PSA testing improves the detection of significant prostate cancers, reduces diagnoses of less severe cases, and helps many men avoid unnecessary biopsies, though its long-term impact on prostate cancer-specific mortality remains uncertain.
How to improve the quality of your MRI
Prostate Cancer UK is analyzing the PRIME trial and GLIMPSE study’s groundbreaking MRI results to assess their potential impact on men with prostate cancer.
Urinary symptoms and prostate cancer-the misconception that may be preventing earlier presentation and better survival outcomes
This article discusses the misconception that urinary symptoms are a primary indicator of prostate cancer, which may delay diagnosis and treatment.
